Trademark Search  /  ICYTE PRISM

ICYTE PRISM

● Live · Pending

U.S. federal trademark · Serial No. 50020040

Mark
ICYTE PRISM
Status
Pending
Serial Number
50020040
Filing Date
July 29, 2026
Class(es)
Class 009, Class 035, Class 042

Owner

IntegriChain, Inc.
03 · Philadelphia, PA, US

Goods & Services

Downloadable computer software using artificial intelligence (AI) for data aggregation, data analytics, data management, data visualization, patient journey analytics, channel analytics, net revenue analytics, commercial data management, market access optimization, drug pricing analysis, rebate management, regulatory compliance monitoring, and data quality stewardship, all for use in the pharmaceutical and life sciences industries; Downloadable computer software for data aggregation, data analytics, data management, data visualization, patient journey analytics, channel analytics, net revenue analytics, commercial data management, market access optimization, drug pricing analysis, rebate management, regulatory compliance monitoring, and data quality stewardship, all for use in the pharmaceutical and life sciences industries

Providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences; Providing an on-line database providing business intelligence in the fields of medical devices, pharmaceuticals and life sciences; Business research and data analysis services in the field of pharmaceutical and life sciences commercial data management, market access optimization, drug pricing analysis, and rebate management; Pharmaceutical cost management services and drug utilization review services

Software as a service (SAAS) services featuring software using artificial intelligence (AI) for data aggregation, data analytics, data management, data visualization, patient journey analytics, channel analytics, net revenue analytics, commercial data management, market access optimization, drug pricing analysis, rebate management, regulatory compliance monitoring, and data quality stewardship, all for use in the pharmaceutical and life sciences industries; Software as a service (SAAS) services featuring software for data aggregation, data analytics, data management, data visualization, patient journey analytics, channel analytics, net revenue analytics, commercial data management, market access optimization, drug pricing analysis, rebate management, regulatory compliance monitoring, and data quality stewardship, all for use in the pharmaceutical and life sciences industries; Platform as a service (PAAS) featuring computer software platforms for data aggregation, data analytics, data management, data visualization, patient journey analytics, channel analytics, net revenue analytics, commercial data management, market access optimization, drug pricing analysis, rebate management, regulatory compliance monitoring, and data quality stewardship, all for use in the pharmaceutical and life sciences industries; Providing on-line non-downloadable software using artificial intelligence (AI) for data aggregation, data analytics, data management, data visualization, patient journey analytics, channel analytics, net revenue analytics, commercial data management, market access optimization, drug pricing analysis, rebate management, regulatory compliance monitoring, and data quality stewardship, all for use in the pharmaceutical and life sciences industries; Providing on-line non-downloadable software for data aggregation, data analytics, data management, data visualization, patient journey analytics, channel analytics, net revenue analytics, commercial data management, market access optimization, drug pricing analysis, rebate management, regulatory compliance monitoring, and data quality stewardship, all for use in the pharmaceutical and life sciences industries

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "ICYTE PRISM" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.